openPR Logo
Press release

Intravenous Immunoglobulin (IVIg) Market Registering a Strong Growth by 2020

05-15-2018 11:53 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Intravenous Immunoglobulin (IVIg) Market Registering a Strong

The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from IVIg to maintain the appropriate level of antibodies in the body.

The global market of IVIg is categorized based on plasma protein and by therapeutic area. The plasma protein segment is further sub-segmented in polyvalent IVIg, albumin, Factor VIII, hyperimmunes (IM&IV) and Factor IX. Polyvalent IVIg sub-segment holds the largest market share in global IVIg market. Moreover, the therapeutic area segment includes immune deficiencies, autoimmune diseases and acute infections. The immune deficiency sub-segment comprises major diseases, such as, hypogammaglobulinemia (primary immune deficiencies), X-linked agammaglobulinemia and acquired compromised immunity conditions (secondary immune deficiencies), featuring low antibody levels. The autoimmune disease sub-segment includes immune thrombocytopenia (ITP) and Inflammatory diseases.

Request for Table of Contents @ https://www.persistencemarketresearch.com/toc/2830

In terms of geography, North America is the largest market for IVIg followed by Europe and Asia. In North America, the U.S. represents the largest market for IVIg. In Europe, Germany, France and the U.K. covers the major share of IVIg market. Asia represents the fastest growing market for IVIg, due to increasing aging population. Elderly people are more susceptible to antibody deficiency diseases.

Globally, IVIG market is witnessing a strong growth due to increasing number of patients with bleeding disorders, rising geriatric population and increasing number of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients. Moreover, increasing investment in healthcare sector is also supporting in growth of IVIg market. In addition, increasing number of patients suffering with autoimmune diseases and other pathological conditions are also supporting growth of IVIg products in the market.

However, stringent regulations hamper the growth of the IVIg market. Several government associations have imposed strict guidelines for appropriate usage of IVIg products. For instance, Canadian Blood Services and National Advisory Committee on Blood and Blood Products of Canada provide practice guidelines on the usage of IVIg products in hematological diseases.

Request to View Sample of Research Report @ https://www.persistencemarketresearch.com/samples/2830

In addition, high treatment cost also impedes growth of IVIg market. Some patients cannot afford IVIg products, due to high cost of their treatment. IVIg products are very expensive as the materials required to produce them cost more and the manufacturing process requires a significant amount of blood samples from donors. The collection of large amount of blood samples is a very complex and tedious process. Furthermore, high risks of side-effects associated with IVIg treatment also restrain growth of the IVIg market. Some of the major side-effects of IVIg treatment are headache, migraine, dizziness, fever, nausea, vomiting, fast heart rate, itching, high blood pressure, cough and abdominal pains. These side-effects inhibit the acceptance of IVIg products by many patients.

Some of the key players operating in IVIg market are Baxter International Inc., Beijing Tiantan Biological Products Co., Ltd., Biotest AG, China Biologic Products, Inc., CSL Limited, Guizhou Taibang Biological Products Co., Ltd., Shanghai RAAS Blood Products Co., Ltd., Octapharma AG, Grifols, S.A, Hualan Biological Engineering Inc., OMRIX Biopharmaceuticals Ltd. and Kedrion S.p.A.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Immunoglobulin (IVIg) Market Registering a Strong Growth by 2020 here

News-ID: 1050092 • Views: 290

More Releases from Persistence Market Research

Aviation Test Equipment Market With An Impressive Double-Digit Growth Rate By 20 …
Aviation sector has been experiencing growth in manufacturing (shipments), especially, the civil aircraft sales. According to Aerospace Industries Association, general aviation shipments rose by 9.7% in 2013 to reach 1,661 units as compared to 2012. This growth combined with the increasing demand for maintenance of older aircrafts is expected to be instrumental in increasing the sales of aviation test equipment. Moreover, the aviation sector especially the defense aircrafts have seen
Aviation Seating Market to Witness Widespread Expansion during 2017 – 2025: Pe …
Over the last few years, the airline industry is the most lucrative market driven by lower oil prices. Moreover, the rise of global economy coupled with an increase in disposable income, people are preferring air transport for the domestic as well as international tour to save travel time. In aircraft, seats are the most prominent part of the cabin that defines the class of service passenger would be avail with
Global Aircraft Filter Market New Innovations, Research and Growth Factor till 2 …
Aircraft Filter Market: Introduction Aircraft filters are distinguished for filtering out contaminants and debris from hydraulic systems, engines, cabins, and avionics. Contaminants include subsumed metal flakes, ash, glass, lint, rubber, various fibers, sand, etc. Over time, contamination intricately impacts aircraft component performance and reliability. The role of an aircraft filter is to eradicate contaminants from a system and ensure fluid and air cleanliness within design tolerances. The aircraft filter market is witnessing
Aircraft Engines Market Sales Forecasts Reveal Positive Growth Through 2025
Aircraft Engines Market: Introduction Aircraft engines are primary propulsion devices that produce the necessary thrust to generate lift for the aircraft to fly. These engines were synonymous in design to reciprocating engines used in automobiles but in the present world, a shift from reciprocating engines to jet engines has been observed. Turbofan engines are the most common type of jet engines used in commercial aircraft, owing to their high bypass ratio

All 5 Releases


More Releases for IVIg

Intravenous Immunoglobulin (IVIg) Market Report 2018: Segmentation by Product (I …
Global Intravenous Immunoglobulin (IVIg) market research report provides company profile for Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Global Intravenous Immunoglobulin (IVIg) Market Future Prospects and Regional Ou …
QYResearchReports.com has announced the addition of a report titled, “Global Intravenous Immunoglobulin (IVIg) Market Research Report 2017” to its depository. The report conducts an in depth assessment of the leading market drivers, trends, restraints, and developments, alongside market figures and market projections. The major participants in the global market for intravenous immunoglobulin tests have been profiled, wherein their product portfolios, business strategies, and market shares are discussed. Get free sample
Intravenous Immunoglobulin (IVIg) Market to Witness Exponential Growth by 2020
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from
Intravenous Immunoglobulin (IVIG) Industry 2016 Market Research Report 2024
Global Intravenous Immunoglobulin (IVIG) Market: Snapshot The global market for intravenous immunoglobulin (IVIG) products and therapies is heading in a positive direction due to several innovative techniques and advantages it offers to clinicians worldwide. The market is expected to expand at a healthy pace in the near future. Factors that will support market’s growth include technological improvements in the methods used for production and purification of IVIG products and an improving
Intravenous Immunoglobulin (IVIG) Market: Rising Prevalence of Neurological Dise …
This report on the global intravenous immunoglobulin (IVIG) market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research